Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

A Pandemic Response Challenge Program to meet COVID-19 related needs

Date added: 23 Apr 2020

Accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians.

Amount
C$15M
Agency or Funder
National Research Council of Canada
Eligibility (if available)

Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise.

Short-term solutions for the COVID-19 emergency in Paraguay

Date added: 11 May 2020

Funding for public and private research into COVID-19 in the areas of epidemiological studies, diagnostics, therapeutics, behavioural science, mental health, and the development of medical and ICT devices.

Amount
PYG 300M to PYG 1B, up to 90% of project costs
Agency or Funder
Consejo Nacional de Ciencia y Tecnología, Paraguay
Eligibility (if available)

Universities, NGOs, private and public sector organisations

Date application deadline

Medical, digital and AI tools for pandemic response

Date added: 20 May 2020

Horizon 2020 funding for fast and easily deployable medical devices, environmental surveillance systems tracking COVID-19 spread, telehealth and data analysis tools.

Amount
€2M to €10M
Agency or Funder
European Commission
Eligibility (if available)

At least 3 legal entities from 3 different Horizon 2020 countries

Foreign participation? (where known)
Yes
Date application deadline

Project funding for Vienna-based companies

Date added: 15 May 2020

Support for rapid development and production of medical devices, software, protective equipment, tools for social distancing, and expansion of diagnostic capacities or logistics solutions.

Amount
Up to €200.000
Agency or Funder
Vienna Business Agency
Eligibility (if available)

Vienna-based companies

Foreign participation? (where known)
No
Date application deadline

Competitive revision and administrative supplements to clinical and translational awardees

Date added: 29 Apr 2020

Additional support for current Clinical and Translational Science Award (CTSA) award recipients for digital health platforms, planning of COVID-19 trials and clinical study data.

Amount
Not limited
Agency or Funder
National Center for Advancing Translational Sciences
Eligibility (if available)

Clinical and Translational Science Award (CTSA) award recipients

Foreign participation? (where known)
No
Date application deadline